🇺🇸
United States · US · US:71336-1002_6ef869cb-8ccd-4339-9991-0fab45da1fbd
OXLUMO
Orange BookUNIISPLATC A16AX18
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAlnylam Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeA16AX18
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1171336100211 VIAL, SINGLE-USE in 1 CARTON (71336-1002-1) / .5 mL in 1 VIAL, SINGLE-USE
Annotations
UNII (FDA Substance ID)
67P6XH37HD
LUMASIRAN SODIUM
RxCUI 2467161
Orange Book
N214103
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "67P6XH37HD",
"rxcui": "2467161",
"inchikey": null,
"display_name": "LUMASIRAN SODIUM",
"substance_type": "nucleicAcid",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"16985a31-f5e4-4557-9266-fc78d4bc5055": {
"match": "brand_token",
"title": "OXLUMO (LUMASIRAN) INJECTION, SOLUTION [ALNYLAM PHARMACEUTICALS, INC.]",
"spl_version": "9",
"published_date": "2025-12-15"
}
},
"productid": "71336-1002_6ef869cb-8ccd-4339-9991-0fab45da1fbd",
"productndc": "71336-1002",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "214103",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 94.5MG BASE/0.5ML (EQ 94.5MG BASE/0.5ML)",
"product_no": "001",
"approval_date": "Nov 23, 2020"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LUMASIRAN SODIUM",
"proprietary_name": "OXLUMO",
"active_ingred_unit": "mg/.5mL",
"application_number": "NDA214103",
"marketing_category": "NDA",
"nonproprietary_name": "lumasiran",
"start_marketing_date": "20201123",
"active_numerator_strength": "94.5"
}Related drugs
Other records sharing ATC code A16AX18.
- ISOxlumoAlnylam Netherlands B.V.
- PLOxlumoAlnylam Netherlands B.V.
- DKOxlumoAlnylam Netherlands B.V.
- FIOxlumoAlnylam Netherlands B.V.
- CZOXLUMOAlnylam Netherlands B.V., Amsterdam
- CAOXLUMOALNYLAM NETHERLANDS B.V.
- NLOxlumo 189 mg/ml, oplossing voor injectieAlnylam Netherlands B.V.
- BEOxlumo 94.5 mg/0.5 mlAlnylam Netherlands
Access this data programmatically
Query OXLUMO and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.